THE BIOHOPE BLOG
Precision Medicine In Immunology
THE BIOHOPE BLOG
Precision Medicine In Immunology
BIOHOPE will participate as biotechnology presenting company in the Anglonordic Life Science Conference
The Anglonordic Life Science Conference is an exclusive event for European investors and R&D companies, mainly proceeding from the Nordics and the UK. Biohope has been selected by the Spanish Institute for Foreign Trade (ICEX) to participate, [...]
BIOHOPE will be part of the European Pavilion at BIO 2022
BIOHOPE has been selected by the European Innovation Council (EIC) as one of the 20 European biotech companies to participate at BIO International Convention 2022, the world's largest biotechnology exhibition. Under the framework of the EIC Overseas [...]
“El inversor europeo y las niñas deben apostar más por la biotecnología”
Los datos dicen que en España, faltan empresas que aporten alto valor añadido en la innovación, mujeres emprendedoras y vocación femenina por la ciencia. Isabel Portero, CEO de Biohope, habla sobre este tema en la entrevista [...]
The European Commission Awards a proposal from Biohope with The Seal of Excellence Certificate.
The Seal of Excellence Certificate is a quality label awarded by the Commission to projects by companies which have been assessed in a call for proposals under a Union instrument and comply with its quality requirements. The [...]
Dra. Isabel Portero included in the report “Referent Women in Innovative Entrepreneurship in Spain”
The report, based on surveys, has been done and coordinated by the High Commissioner of Entrepreneurship in Spain, which is an organism of the Government Presidency. This recognition reflects the role Dra. Portero is doing in [...]
Immunobiogram® has been granted a US patent by USPTO
Biohope´s lead product, the Immunobiogram®, has been granted a US patent by the United States Patent and Trademark Office. This new patent complements and consolidates Biohope´s intellectual property protection facilitating the commercial expansion in a key market [...]
